Key facts
- This page summarizes Braden M. Leonard's Form 4 filing for Satsuma Pharmaceuticals, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 23 Nov 2022, 08:38.
Braden M. Leonard - 21 Nov 2022 Form 4 Insider Report for Satsuma Pharmaceuticals, Inc.
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 21 Nov 2022
- Net transaction value
- +$106,740
- SEC form
- 4
- Accepted by SEC
- 23 Nov 2022, 08:38:16 UTC
- Prior SEC filing
- 18 Nov 2022
- Next SEC filing
- 25 Nov 2022
- Source filing
- View source filing
- Reporting owner signature
- Braden Michael Leonard
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Braden M. Leonard filed Form 4 for Satsuma Pharmaceuticals, Inc. on 23 Nov 2022.
Change
- Previous filing in this sequence was filed on 18 Nov 2022.
- Current net transaction value: +$106,740.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
STSA
transaction
Common Stock
Purchase
- Transaction value
- $106,740
- Shares
- +150,000
- Change %
- Price
- $0.7116
- Shares after
- 150,000
- Date
- 21 Nov 2022
- Ownership
- Direct
- Footnotes
- F2
STSA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 6,440,000
- Date
- 21 Nov 2022
- Ownership
- Holding of BML Investment Partners, L.P.
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein
Footnote F2
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.70 to $0.73. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.